Project Oncology®

Analyzing Dato-DXd for Non-Squamous NSCLC with Brain Metastases


Listen Later

Host: Jacob Sands, MD
Guest: Aaron Lisberg, MD

Unfortunately, brain metastases are very common in patients with non-small cell lung cancer (NSCLC). That’s why the phase 3 TROPION-Lung01 trial examined the efficacy and safety of datopotamab deruxtecan (Dato-DXd) for advanced non-squamous NSCLC with brain metastases. Joining Dr. Jacob Sands to share the results presented at the 2024 ESMO Congress is thoracic medical oncologist Dr. Aaron Lisberg.

...more
View all episodesView all episodes
Download on the App Store

Project Oncology®By ReachMD

  • 4.5
  • 4.5
  • 4.5
  • 4.5
  • 4.5

4.5

2 ratings


More shows like Project Oncology®

View all
Journal of Clinical Oncology (JCO) Podcast by American Society of Clinical Oncology (ASCO)

Journal of Clinical Oncology (JCO) Podcast

39 Listeners

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast by PVI, PeerView Institute for Medical Education

PeerView Oncology & Hematology CME/CNE/CPE Video Podcast

10 Listeners

ASCO Daily News by American Society of Clinical Oncology (ASCO)

ASCO Daily News

59 Listeners

Core IM | Internal Medicine Podcast by Core IM Team

Core IM | Internal Medicine Podcast

1,142 Listeners

Two Onc Docs by Sam and Karine

Two Onc Docs

191 Listeners

Oncology Brothers: Practice-Changing Cancer Discussions by Oncology Brothers

Oncology Brothers: Practice-Changing Cancer Discussions

45 Listeners

CME in Minutes: Education in Oncology & Hematology by Answers in CME

CME in Minutes: Education in Oncology & Hematology

7 Listeners